The next board meeting for Silence Therapeutics PLC (ADR) is on 27 Feb 2026 for the purpose of Silence Therapeutics PLC Fourth Quarter Earnings Results for 2025See details
Silence Therapeutics PLC (ADR) has a share price target of US$ 33, revenue growth forecast of -81.6%, and profit growth estimate of -121.9% for FY25, based on top 6 analyst calls.